Farid Keramati

Farid Keramati

Auto-generated profile, based on publicly available information

Farid Keramati

Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
WHWouter A. van der Heijden
Wouter A. van der Heijden
LWLisa Van de Wijer
Lisa Van de Wijer
FKFarid Keramati
Farid Keramati
WTWim Trypsteen
Wim Trypsteen
SRSofie Rutsaert
Sofie Rutsaert
QMQuirijn De Mast
Quirijn De Mast
Chronic inflammation and immune dysfunction play a key role in the development of non-AIDS–related comorbidities. The aim of our study was to characterize the functional phenotype of immune cells in people living with HIV (PLHIV). We enrolled a cross-sectional cohort study of PLHIV on stable antiretroviral therapy and healthy controls. We assessed ex vivo cytokine production capacity and transcriptomics of monocytes and T cells upon bacterial, fungal, and viral stimulation. PLHIV exhibited an exacerbated proinflammatory profile in monocyte-derived cytokines, but not in lymphocyte-derived cytokines. Particularly, the production of the IL-1β to imiquimod, E . coli LPS, and Mycobacterium tuberculosis was increased, and this production correlated with plasma concentrations of high-sensitivity C-reactive protein and soluble CD14. This increase in monocyte responsiveness remained stable over time in subsequent blood sampling after more than 1 year. Transcriptome analyses confirmed priming of the monocyte IL-1β pathway, consistent with a monocyte-trained immunity phenotype. Increased plasma concentrations of β-glucan, a well-known inducer of trained immunity, were associated with increased innate cytokine responses. Monocytes of PLHIV exhibited a sustained proinflammatory immune phenotype with priming of the IL-1β pathway. Training of the innate immune system in PLHIV likely plays a role in long-term HIV complications and provides a promising therapeutic target for inflammation-related comorbidities.

18 April 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
FKFarid Keramati
Farid Keramati
GLGuus P. Leijte
Guus P. Leijte
NBNiklas Bruse
Niklas Bruse
IGInge Grondman
Inge Grondman
EHEhsan Habibi
Ehsan Habibi
MKMatthijs Kox
Matthijs Kox
Systemic inflammatory conditions are classically characterized by an acute hyperinflammatory phase, followed by a late immunosuppressive phase that elevates the susceptibility to secondary infections. Comprehensive mechanistic understanding of these phases is largely lacking. To address this gap, we leveraged a controlled, human in vivo model of lipopolysaccharide (LPS)-induced systemic inflammation encompassing both phases. Single-cell RNA sequencing during the acute hyperinflammatory phase identified an inflammatory CD163 + SLC39A8 + CALR + monocyte-like subset (infMono) at 4 h post-LPS administration. The late immunosuppressive phase was characterized by diminished expression of type I interferon (IFN)-responsive genes in monocytes, impaired myelopoiesis and a pronounced attenuation of the immune response on a secondary LPS challenge 1 week after the first. The infMono gene program and impaired myelopoiesis were also detected in patient cohorts with bacterial sepsis and coronavirus disease. IFNβ treatment restored type-I IFN responses and proinflammatory cytokine production and induced monocyte maturation, suggesting a potential treatment option for immunosuppression.

5 May 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
LLLida Langroudi
Lida Langroudi
FJFatemeh Jamshidi-Adegani
Fatemeh Jamshidi-Adegani
ASAbbas Shafiee
Abbas Shafiee
ARAli Hosseini Rad
Ali Hosseini Rad
FKFarid Keramati
Farid Keramati
MSMasoud Soleimani
Masoud Soleimani

1 January 2015 in Stem Cell Fundamentals and Practice
Verified
Journal Article
Open access
PDF file
ARAli Hosseini Rad
Ali Hosseini Rad
LLLida Langroudi
Lida Langroudi
FKFarid Keramati
Farid Keramati
EAEhsan Arefian
Ehsan Arefian

7 October 2022 in medRxiv
Verified
Preprint
Open access
PDF file
FKFarid Keramati
Farid Keramati
GLGuus P. Leijte
Guus P. Leijte
NBNiklas Bruse
Niklas Bruse
IGInge Grondman
Inge Grondman
EHEhsan Habibi
Ehsan Habibi
MKMatthijs Kox
Matthijs Kox
Systemic inflammation (SI) plays a detrimental role in various conditions with high mortality rates 1–4 . SI manifests an acute hyperinflammation followed by long-lasting immunosuppression, increasing patients’ risks for secondary infections and impaired clinical outcomes 5–7 . Due to the extensive heterogeneity in SI etiology, the mechanisms governing these states are incompletely understood. Here, we characterized acute and late effects of lipopolysaccharide (LPS)-induced SI (LPS-SI 8 ) on blood monocytes and bone marrow (BM) cells of healthy volunteers. Like clinical SI, LPS administration elicited a profound but transient acute response. Single-cell transcriptomic analysis of acute LPS-SI unveiled loss of BM monocytes and appearance of an inflammatory monocyte-like (i-Mono’s) population, expressing gene programs similar to early-stage sepsis patients 9 . In the ensuing late phase of LPS-SI, we observed reduced expression of interferon type I (IFN-I) responsive genes in monocytes and profound attenuation of in vivo response to a second LPS challenge. Furthermore, late LPS-SI led to impaired myelopoiesis with a loss of intermediate and non-classical monocytes. In accordance, we show compromised myelopoiesis also occurs in late-stage sepsis. Finally, IFNβ treatment reversed LPS-induced immunosuppression in monocytes. Our results reveal long-lasting effects of SI on myelopoiesis and substantiate the importance of IFN-I in the pathophysiology of SI-induced immunosuppression.

10 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAnniek H.G. Stuut
Anniek H.G. Stuut
PBPeter Brazda
Peter Brazda
AJAnke Janssen
Anke Janssen
AVAnna Vyborova
Anna Vyborova
EKE. Karaiskaki
E. Karaiskaki
ZSZsolt Sebestyen
Zsolt Sebestyen
Immune reconstitution after allogeneic hematopoietic stem cell transplantation is influenced by graft-composition and viral reactivation, but the combined long-term impact on αβ and γδT cells remains unclear. We analyzed a cohort of 213 patients receiving either αβT cell-depleted grafts (n=146; graft engineering that removes donor αβT cells) or T cell-replete grafts (n=67; containing donor T cells). Longitudinal immune phenotyping was integrated with bulk and single-cell TCR repertoire and transcriptomic profiling. CMV reactivation was associated with expansion of CD8 + αβT cells across both transplant types and with numerical dominance of Vδ2 − γδT cells specifically in αβT cell-depleted recipients. Vδ2 − γδT cells underwent early polyclonal expansion followed by repertoire focusing, independent of CMV, whereas αβT cells remained clonally restricted. Reduced early Vδ2 + γδTCR diversity was associated with EBV reactivation. Single-cell and TCR tracking analyses revealed long-term persistence of donor-derived Vδ2 + γδTCRs, whereas Vδ1 + γδ and αβT cell repertoires were predominantly rebuilt de novo. Despite de novo rebuilding, αβTCR repertoire diversity diverged by platform at one year: αβT cell-depleted recipients exhibited marked (hyper)expansion of αβTCR clonotypes and lower diversity than T cell-replete recipients, indicating a durable imprint of graft engineering on αβTCR-clonality. Transcriptomic profiling showed that post-transplant T cells predominantly adopted effector programs, with platform-dependent polarization toward cytotoxic signatures in αβT cell–depleted recipients and toward AREG-associated tissue-repair signatures in T cell–replete recipients, consistent with wound-healing functions. In conclusion, transplantation platforms imprint durable clonal and transcriptional remodeling of αβ and γδT cells, while viral reactivation primarily amplifies expansion without fundamentally reshaping repertoire architecture. Abstract Figure: